Events, Pharmaceutical

Aptar Pharma Receives InnoPack 2020 China Award

The award recognized Aptar Pharma’s innovative PureHale® device and Pacifica Duo Actuator.

12 Apr 2021

Aptar Pharma was proud to receive an InnoPack China Award recently, in recognition of Aptar Pharma’s well-established Bag-on-Valve Technology (BOV) Platform, with a special focus on our innovative PureHale® device and Pacifica Duo Actuator.

PureHale® is a portable and ready-to-use drug delivery solution designed for upper respiratory care. An industry first, this nebulizer-like device distributes a continuous fine mist to gently cleanse, moisturize and soothe the upper respiratory tract. Aptar Pharma’s Pacifica Duo is a twistable actuator that fulfills two needs in one applicator – spray for gentle application and jet for rinsing -providing flexibility to users.

The InnoPack China Awards were launched in 2020 by InnoPack China and were designed to recognize innovative pharmaceutical packaging products, solutions and technologies. Celebrating the latest industry developments, the awards also intended to provide inspiration to packaging companies and drive innovation with the pharmaceutical packaging industry.

“We are really pleased to see Aptar Pharma’s Bag-on-Valve (BOV) Technology Platform and PureHale® win an InnoPack China Award.  With special focus on BOV technology innovation, we have launched the industry’s first cordless, ready-to-use, nebulizer-like system PureHale®, which enables “better breathing made easy,” said Xin Yao Vice-President & General Manager, Aptar Pharma, Northeast Asia (NEA).  “Aptar Pharma is leading the way in frontier drug delivery techniques.  With our sustainable innovation capability, we will be continuing to collaborate with Chinese customers to deliver better user experience and outcomes,” she added.

InnoPack China, part of CPhI & P-MEC China, was held in Shanghai from December 16-18, 2020.


Back To Top